98%
921
2 minutes
20
Introduction: The most common type of leukemia is acute myeloid leukemia (AML) with the lowest survival rate among all of the leukemias particularly in adults. The evidence has shown that dysregulation of miRNA expression is associated with AML. Therefore, the aim of this systematic review was to clarify the role of miR-181a expression in AML.
Methods And Analysis: In the present study, observational studies of the roles of miR-181a expression in patients with AML will be included. Standards and indicators test should be performed for all patients. We will search PubMed, SCOPUS and ISI Web of Science with no restriction of language. The outcomes will be reviewed for association between miR-181a level and AML progression and the strength of this relationship with AML will be investigated. Selection of articles and data extraction will be performed by two independent reviewers. STROBE will be used for assessment of study quality. Publication bias and data synthesis will be an assessment by funnel plots and Beggs and Egger's tests using Stata software V.12.1.
Ethics And Dissemination: There are no ethical issues.
Trial Registration Number: This systematic review protocol is registered in the PROSPERO (International Prospective Register of Systematic Reviews), and registration number CRD42016040080.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913575 | PMC |
http://dx.doi.org/10.1016/j.isjp.2018.12.001 | DOI Listing |
Biochemistry (Mosc)
August 2025
Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115522, Russia.
One of the hallmarks of malignant neoplasms is their ability to sustain growth under hypoxic conditions resulting from insufficient oxygenation of tumor tissues. Prolonged hypoxia is associated with the gradual adaptation of tumor cells to low oxygen levels, leading to the enhanced survival, increased metastatic potential, and development of resistance to anticancer therapies. The aim of this study was to investigate the mechanisms underlying adaptation of breast cancer cell to prolonged hypoxia and maintenance of the hypoxia-tolerant phenotype.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Warsaw Genomics, Żwirki i Wigury 101, 02-089 Warsaw, Poland.
SLC5A8 is a protein coded by the gene, and has been proposed as a tumor suppressor and iodide transporter. Its expression is reduced in papillary thyroid carcinoma (PTC), yet the mechanisms underlying this phenomenon are largely unknown. We hypothesized that expression in PTC is reduced by microRNAs and can be modulated by their inhibition.
View Article and Find Full Text PDFDiseases
August 2025
Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany.
Background/objectives: Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal genetic disease caused by a silent mutation in the LMNA gene, leading to the production of progerin, a defective prelamin A variant. Progerin accumulation disrupts nuclear integrity, alters chromatin organization, and drives systemic cellular dysfunction. While autophagy and inflammation are key dysregulated pathways in HGPS, the role of microRNAs (miRNAs) in these processes remains poorly understood.
View Article and Find Full Text PDFBiochem J
September 2025
Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Glycogen synthase kinase-3α (GSK-3α) is a multifunctional kinase that plays roles in the pathogenesis of various cardiac diseases, including ischemia and pressure overload and ischemia-reperfusion-induced injury. It regulates key cellular processes such as cardiac cell proliferation, apoptosis, metabolism, and inflammation. However, its role in regulating cardiac microRNAs (miRNAs) remains unknown.
View Article and Find Full Text PDFPhysiol Rep
August 2025
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, School of Medicine, Palo Alto, California, USA.
MicroRNAs (miRs) regulate the translation of target genes often in a cell-type specific manner. We previously demonstrated that downregulation of either miR-181a or miR-200c with intracranial injection of an inhibitor is protective against experimental stroke in mice. Here, we generated genetic lines of inducible Ca-calmodulin kinase IIα (CKIIα) neuronal miR-181a/b-1 and miR-141/200c cluster deletion to investigate whether the protective effect of their inhibition could be neuron-specific.
View Article and Find Full Text PDF